Thomas Ryckewaert

Thomas Ryckewaert

UNVERIFIED PROFILE

Are you Thomas Ryckewaert?   Register this Author

Register author
Thomas Ryckewaert

Thomas Ryckewaert

Publications by authors named "Thomas Ryckewaert"

Are you Thomas Ryckewaert?   Register this Author

13Publications

-Reads

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma.

Eur J Cancer 2018 Aug 11;99:28-36. Epub 2018 Jun 11.

Department of Clinical Research and Innovation, Centre Oscar Lambret, 3 rue Combemale, 59000 Lille, France; Paris-Saclay University, Univ. Paris-Sud, CESP, INSERM, Gustave Roussy, 94805 Villejuif, France. Electronic address:

View Article
August 2018

[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].

Bull Cancer 2017 Mar 13;104(3):208-212. Epub 2016 Dec 13.

Centre Oscar-Lambret, département d'oncologie médicale, 3, rue Combemale, 59020 Lille cedex, France; CHRU de Lille, SIRIC OncoLille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. Electronic address:

View Article
March 2017

[Docetaxel and prostate cancer: Early but not too early].

Bull Cancer 2015 Sep 30;102(9):710-2. Epub 2015 Jul 30.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France.

View Article
September 2015

Selection of ultimately ill cancer patients able to fulfill a questionnaire: Identification of inherent biases.

Bull Cancer 2015 Sep 30;102(9):730-6. Epub 2015 Jul 30.

University Lille 3, URECA EA 1059 (Research Unit: Cognitive and Affective Sciences), UFR de psychologie, rue du Barreau, BP 60149, 59653 Villeneuve d'Ascq cedex, France; University Lille 2, EA 264 (Resarch Unit: Epidemiology and Care Quality) and SIRIC ONCoLille, Platform 4, place de Verdun, 59045 Lille cedex, France. Electronic address:

View Article
September 2015

Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.

Crit Rev Oncol Hematol 2015 Jul 30;95(1):125-31. Epub 2015 Jan 30.

Medical Oncology Department, Centre Oscar Lambret, Lille, France; Research Unit (EA2694), Medical School University, Lille-Nord de France University, Lille, France. Electronic address:

View Article
July 2015

Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.

Eur J Cancer 2015 Jan 9;51(2):202-9. Epub 2014 Dec 9.

Medical Oncology Department, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille cedex, France; Clinical Resarch and Methodological Platform, SIRIC OncoLille, Lille, France. Electronic address:

View Article
January 2015

What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trials.

Bull Cancer 2014 Apr;101(4):E19-24

Lille Nord-de-France University, Unit Research (EA 2694) Medical School, 1, place de verdun, 59000 Lille, France, Centre Oscar-Lambret, Methodology and Biostatistics Unit, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.

View Article
April 2014

Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.

Crit Rev Oncol Hematol 2012 Nov 11;84(2):213-23. Epub 2012 Apr 11.

Department of medical oncology, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille cedex, France.

View Article
November 2012